Saposin C-LBPA interaction in late-endosomes/lysosomes

被引:46
作者
Chu, ZT
Witte, DP
Qi, XY
机构
[1] Childrens Hosp Res Fdn, Div Human Genet, Cincinnati, OH 45229 USA
[2] Childrens Hosp Res Fdn, Program Human Genet, Cincinnati, OH 45229 USA
[3] Childrens Hosp Res Fdn, Div Pediat Pathol, Cincinnati, OH 45229 USA
关键词
lysobisphosphatidic acid; multivesicular body; prosaposin; saposin; colocalization; electron microscopy;
D O I
10.1016/j.yexcr.2004.09.029
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Acidic phospholipids and saposins associations are involved in the degradation process of glycosphingolipids/sphingolipids in late endosomes/lysosomes. In this report, we showed the colocalization of saposin C and lysobisphosphatidic acid (LBPA) in human fibroblasts by using cytoimmunofluorescence analysis. This colocalization pattern was not seen with other saposins. Large numbers of saposins A, B, and D illustrated the staining patterns that differ from LBPA. In addition, ingested anti-LBPA antibody altered the location of saposin C in human wild-type fibroblasts. In vitro assays demonstrated that saposin C at nM concentrations induced membrane fusion of LBPA containing phospholipid vesicles. Under the same condition, other saposins had no fusion induction on these vesicles. These results suggested a specific interaction between saposin C and LBPA. Total saposin-deficient fibroblasts showed a massive accumulation of multivesicular bodies (MVBs) by electron microscopic analysis. No significant increase of MVBs was found in saposins A and B deficient cells. Interestingly, the accumulated MVBs were significantly reduced by loading saposin C alone into the total saposin-deficient cells. Therefore, we propose that saposin C-LBPA interaction plays a role in the regulation of MVB formation in cells. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:300 / 307
页数:8
相关论文
共 34 条
[1]  
Burkhardt JK, 1997, EUR J CELL BIOL, V73, P10
[2]   THE CEREBROSIDE SULFATE ACTIVATOR (SAPOSIN-B, SAP-1) - A MANY FACETED PROTEIN [J].
FLUHARTY, AL .
TRENDS IN GLYCOSCIENCE AND GLYCOTECHNOLOGY, 1995, 7 (35) :167-189
[3]  
FUJIBAYASHI S, 1986, BIOCHIM BIOPHYS ACTA, V875, P554
[4]  
FUJIBAYASHI S, 1986, J BIOL CHEM, V261, P5339
[5]   The endocytic pathway: A mosaic of domains [J].
Gruenberg, J .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (10) :721-730
[6]   SPHINGOLIPID ACTIVATOR PROTEIN-DEFICIENCY IN A 16-WEEK-OLD ATYPICAL GAUCHER DISEASE PATIENT AND HIS FETAL SIBLING - BIOCHEMICAL SIGNS OF COMBINED SPHINGOLIPIDOSES [J].
HARZER, K ;
PATON, BC ;
POULOS, A ;
KUSTERMANNKUHN, B ;
ROGGENDORF, W ;
GRISAR, T ;
POPP, M .
EUROPEAN JOURNAL OF PEDIATRICS, 1989, 149 (01) :31-39
[7]   THE EFFECT OF CARBOHYDRATE REMOVAL ON STABILITY AND ACTIVITY OF SAPOSIN-B [J].
HIRAIWA, M ;
SOEDA, S ;
MARTIN, BM ;
FLUHARTY, AL ;
HIRABAYASHI, Y ;
OBRIEN, JS ;
KISHIMOTO, Y .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 303 (02) :326-331
[8]   Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): Its mechanism and inhibition by ganglioside [J].
Hiraiwa, M ;
Martin, BM ;
Kishimoto, Y ;
Conner, GE ;
Tsuji, S ;
OBrien, JS .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 341 (01) :17-24
[9]   A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation [J].
Hulková, H ;
Cervenková, M ;
Ledvinová, J ;
Tochácková, M ;
Hrebicek, M ;
Poupetová, H ;
Befekadu, A ;
Berná, L ;
Paton, BC ;
Harzer, K ;
Böör, A ;
Smíd, F ;
Elleder, M .
HUMAN MOLECULAR GENETICS, 2001, 10 (09) :927-940
[10]   Receptor downregulation and multivesicular-body sorting [J].
Katzmann, DJ ;
Odorizzi, G ;
Emr, SD .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (12) :893-905